These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Effect of beta-blocking agents in hyperthyroidism. Földes J; Bános C; Borvendég J; Gyertyánfy G Acta Med Acad Sci Hung; 1979; 36(4):375-80. PubMed ID: 45285 [TBL] [Abstract][Full Text] [Related]
25. [Refractory heart failure. Positive inotropes and beta blockers: alternative or complementary treatments?]. Sabbadini G; Ciaccheri M; Castelli G; Sinagra G; Di Lenarda A Ital Heart J Suppl; 2002 Aug; 3(8):804-11. PubMed ID: 12407835 [TBL] [Abstract][Full Text] [Related]
26. Insulin inhibits beta-adrenergic action in ischemic/reperfused heart: a novel mechanism of insulin in cardioprotection. Yu QJ; Si R; Zhou N; Zhang HF; Guo WY; Wang HC; Gao F Apoptosis; 2008 Feb; 13(2):305-17. PubMed ID: 18165901 [TBL] [Abstract][Full Text] [Related]
27. Beta-blockade during sepsis: inspired or insane? Meldrum DR Crit Care Med; 2005 Oct; 33(10):2433-4. PubMed ID: 16215413 [No Abstract] [Full Text] [Related]
28. Sepsis and beta-blockade: a look into diastolic function. Astuto M Curr Med Res Opin; 2015; 31(10):1827-8. PubMed ID: 26211819 [TBL] [Abstract][Full Text] [Related]
29. A new frontier for an old drug? A word of caution for beta-blockers in sepsis! Maybauer MO; Maybauer DM Curr Med Res Opin; 2015; 31(10):1829-30. PubMed ID: 26296157 [TBL] [Abstract][Full Text] [Related]
30. How to slow down septic hearts? Rozec B J Mol Cell Cardiol; 2014 Sep; 74():112-4. PubMed ID: 24838100 [No Abstract] [Full Text] [Related]
31. Heart disease: recruitment of MEF2 activity by β-blockers wards off cardiomyocyte death. Hashemi S; Wales S; Miyake T; McDermott JC Cell Death Dis; 2015 Oct; 6(10):e1916. PubMed ID: 26469965 [No Abstract] [Full Text] [Related]
32. Bench-to-bedside review: Beta-adrenergic modulation in sepsis. de Montmollin E; Aboab J; Mansart A; Annane D Crit Care; 2009; 13(5):230. PubMed ID: 19863760 [TBL] [Abstract][Full Text] [Related]
33. Is It Time to Beta Block the Septic Patient? Pemberton P; Veenith T; Snelson C; Whitehouse T Biomed Res Int; 2015; 2015():424308. PubMed ID: 26557668 [TBL] [Abstract][Full Text] [Related]
34. N-acetylcysteine for sepsis and systemic inflammatory response in adults. Visvanathan V Crit Care Nurse; 2013 Aug; 33(4):76-7. PubMed ID: 23908173 [No Abstract] [Full Text] [Related]
35. Bench to bedside: A role for erythropoietin in sepsis. Walden AP; Young JD; Sharples E Crit Care; 2010; 14(4):227. PubMed ID: 20727227 [TBL] [Abstract][Full Text] [Related]
36. β-Blockers in Patients With Sepsis: Putting the Puzzle Together, Piece by Piece. Hollenberg SM JAMA; 2023 Nov; 330(17):1627-1628. PubMed ID: 37877588 [No Abstract] [Full Text] [Related]
37. Beta-blockers and the criteria of SIRS. Kittisupamongkol W Swiss Med Wkly; 2009 Jan; 139(3-4):56. PubMed ID: 19169905 [No Abstract] [Full Text] [Related]
38. Beta blockade: the right time, the right dose, the right receptor! Al-Mousawi AM; Jeschke MG; Herndon DN Crit Care Med; 2010 Feb; 38(2):688-9. PubMed ID: 20083925 [No Abstract] [Full Text] [Related]
39. Gut mucosal permeability, β1 receptor blockers and gastric tonometry: the time is now! Gutierrez G; Ballarino G Intensive Care Med; 2011 Nov; 37(11):1721-2. PubMed ID: 21847650 [No Abstract] [Full Text] [Related]
40. β-Blocker Therapy Could Inflate the Diagnosis of Severe Sepsis. Savas G; Kalay N Crit Care Med; 2016 Aug; 44(8):e765-6. PubMed ID: 27428141 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]